Pharmacologic Treatments for Acute Respiratory Distress Syndrome
Authors:
- 18 September 2021
- journal article
- research article
- Published by Elsevier in Critical Care Clinics
- Vol. 37 (4) , 877-893
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Vitamin C: A Novel Regulator of Neutrophil Extracellular Trap FormationNutrients, 2013
- The acute respiratory distress syndromeJournal of Clinical Investigation, 2012
- A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury*Critical Care Medicine, 2012
- Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trialThe Lancet, 2012
- Randomized, Placebo-controlled Clinical Trial of an Aerosolized β2-Agonist for Treatment of Acute Lung InjuryAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trialCritical Care, 2011
- Simvastatin Decreases Lipopolysaccharide-induced Pulmonary Inflammation in Healthy VolunteersAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysisBMJ, 2008
- How corticosteroids control inflammation: Quintiles Prize Lecture 2005British Journal of Pharmacology, 2006
- High-Dose Corticosteroids in Patients with the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1987